Cyclin M3 Antibody [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97251IR
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with E. coli-derived Human Cyclin M3 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Cyclin M3 Antibody [DyLight 755]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cyclin M3
Alternate Names
ACDP3cyclin-M3, ancient conserved domain protein 3, Ancient conserved domain-containing protein 3, cyclin M3, Cyclin-M3, DKFZp434I1016, FLJ20018, metal transporter CNNM3
Gene Symbol
CNNM3
Additional Cyclin M3 Products
Product Documents for Cyclin M3 Antibody [DyLight 755]
Product Specific Notices for Cyclin M3 Antibody [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...